Pharming - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPharming

Pharming(PHAR)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Annual sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Ruconest	C1 esterase inhibitor (recombinant), Conestat alfa	2014-07-16		Hereditary angioedemas
Joenja	Leniolisib	2023-03-24	2032	Primary immunodeficiency diseases

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

neuromyelitis optica

,

renal insufficiency

,

acute kidney injury

,

,

reperfusion injury

,

kidney transplantation

,

chronic kidney failure

,

kidney diseases

,

delayed graft function

,

graft rejection

,

ischemic stroke

,

renal cell carcinoma

,

urologic neoplasms

,

,

,

non-small-cell lung carcinoma

,

stomach neoplasms

,

head and neck neoplasms

,

,

,

,

coronavirus infections

,

communicable diseases

,

chronic renal insufficiency

,

traumatic brain injuries

,

craniocerebral trauma

,

,

myocardial infarction

,

non-st elevated myocardial infarction

,

,

,

subarachnoid hemorrhage

,

inborn genetic diseases

,

wounds and injuries

,

,

,

,

multiple organ failure

,

innate immunity

,

,

,

hereditary angioedemas

,

hereditary angioedema types i and ii

,

,

,

chronic fatigue syndrome

,

common variable immunodeficiency

,

,

prodromal symptoms

,

immunologic tests

,

graft vs host disease

,

systemic mastocytosis

,

,

immunologic deficiency syndromes

,

primary immunodeficiency diseases

,

lymphadenopathy

,

,

,

,

enterovirus infections

overactive urinary bladder

,

urinary incontinence

,

urinary bladder diseases

,

,

Sodium chloride

urinary bladder neoplasms

,

non-muscle invasive bladder neoplasms

C1 esterase inhibitor

renal insufficiency

,

delayed graft function

,

acute kidney injury

,

,

kidney transplantation

,

graft rejection

,

myocardial infarction

,

non-st elevated myocardial infarction

,

,

ischemic stroke

,

,

,

coronavirus infections

,

communicable diseases

,

hereditary angioedemas

,

,

inborn genetic diseases

,

breast neoplasms

,

triple negative breast neoplasms

neuromyelitis optica

,

renal insufficiency

,

acute kidney injury

,

,

reperfusion injury

,

kidney transplantation

,

chronic kidney failure

,

kidney diseases

,

delayed graft function

,

graft rejection

,

ischemic stroke

,

,

coronavirus infections

,

communicable diseases

,

chronic renal insufficiency

,

traumatic brain injuries

,

craniocerebral trauma

,

,

myocardial infarction

,

non-st elevated myocardial infarction

,

,

,

subarachnoid hemorrhage

,

inborn genetic diseases

,

wounds and injuries

,

,

,

,

multiple organ failure

,

innate immunity

,

,

,

hereditary angioedemas

,

hereditary angioedema types i and ii

,

,

,

chronic fatigue syndrome

,

common variable immunodeficiency

,

,

prodromal symptoms

,

immunologic tests

,

graft vs host disease

,

systemic mastocytosis

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use